Sophie Sassard – Page 4

Xstrata shareholders to vote on pay, deal separately: sources

August 23, 2021 at 3:01 p.m.

(Reuters) - Xstrata shareholders will vote on a proposed management retention package before deciding on Glencore's $32 billion bid, two people familiar with the talks told Reuters, a structure designed...

Orcel’s revolution only just starting at UBS

December 24, 2018 at 4:34 p.m.

LONDON (Reuters) - A cultural revolution is under way at UBS under new investment bank boss Andrea Orcel, who has lifted morale by bringing in clients but raised fears among...

Xstrata board expected to back Glencore bid next week

August 23, 2021 at 2:07 p.m.

LONDON (Reuters) - Xstrata's board is expected to recommend Glencore's revised $34 billion bid as early as next week, sources close to the deal say, although it may come with...

Xstrata board expected to back Glencore bid next week

December 24, 2018 at 3:45 p.m.

LONDON (Reuters) - Xstrata's board is expected to recommend Glencore's revised $34 billion bid as early as next week, sources close to the deal say, although it may come with...

Vivendi tests appetite for Activision: sources

August 23, 2021 at 10:19 a.m.

LONDON (Reuters) - Vivendi, the French media-to-telecoms conglomerate, has started testing the appetite of possible bidders for its video game business Activision Blizzard, five sources close the situation said on...

Vivendi tests appetite for Activision: sources

December 24, 2018 at 8:52 a.m.

LONDON (Reuters) - Vivendi, the French media-to-telecoms conglomerate, has started testing the appetite of possible bidders for its video game business Activision Blizzard, five sources close the situation said on...

Fears over Spain linger despite banking plan

December 24, 2018 at 3:18 a.m.

LONDON (Reuters) - Spain's clean-up plan for its troubled banks lacks some of the key ingredients that helped other governments restore faith in their financial sectors, restructuring experts said, pointing...

Biotech targets fight back as Big Pharma circles

August 23, 2021 at 5:37 a.m.

LONDON (Reuters) - Biotech companies are fighting back in an unequal battle with Big Pharma, helped by a small but powerful cohort of investors who dominate the companies' share registers....

Biotech targets fight back as Big Pharma circles

December 24, 2018 at 2:08 a.m.

LONDON (Reuters) - Biotech companies are fighting back in an unequal battle with Big Pharma, helped by a small but powerful cohort of investors who dominate the companies' share registers....

Exclusive: RBS M&A bankers preparing for boutique spin-off

August 23, 2021 at 5:11 a.m.

(Reuters) - Royal Bank of Scotland is planning to spin off its mergers and acquisitions business to some of its top bankers, sources said, forming a new advisory boutique with...

All Stories